(MedPage Today) — The ranibizumab ocular implant (Susvimo) reduces the need for frequent intravitreal anti-VEGF injections in patients with neovascular age-related macular degeneration or diabetic macular edema, and structural updates to the device…
Source link : https://www.medpagetoday.com/meetingcoverage/arvovideopearls/115925
Author :
Publish date : 2025-06-05 18:31:00
Copyright for syndicated content belongs to the linked Source.
